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Abstract: The morbidity and mortality of pulmonary embolism (PE) have been found to be 
related to early diagnosis and appropriate treatment. The examinations used to diagnose PE 
are expensive and not always easily accessible. These options include noninvasive exami-
nations, such as clinical pretests, ELISA D-dimer (DD) tests, and volumetric capnography 
(VCap). We report the case of a patient whose diagnosis of PE was made via pulmonary 
arteriography. The clinical pretest revealed a moderate probability of the patient having PE, 
and the DD result was negative; however, the VCap associated with arterial blood gases result 
was positive. The patient underwent all noninvasive exams following admission to hospital 
and again eight months after discharge. Results gained from invasive tests were similar 
to those produced by image exams, highlighting the importance of VCap as an important 
noninvasive tool.
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Pulmonary embolism (PE) is the third most common cause of death in the United 
States, with an estimated 100,000 deaths and over 780,000 clinically apparent 
cases diagnosed annually.1 Results of autopsy studies have indicated that most 
cases of venous thromboembolism (VTE) go undiagnosed, even when they are 
the immediate cause of death. When PE is missed on initial presentation, a delay 
of 24 hours, during which anticoagulation occurs, increases the risk of recurrent 
embolism from 4% to 23%, and leads to a fivefold increase in the likelihood of 
death within a year.2 Traditional examinations used to detect PE are generally 
expensive and are not able to be carried out in all hospitals, which increases dif-
ficulty of access.
In the search for a cost-effective screening approach to PE, ELISA D-dimer (DD) 
testing shows promise, often sparing patients unnecessary radiation and expense. How-
ever, DD has limitations, and gaining an understanding of these limitations in practice 
is vital. Additionally, measuring the volumetric capnography (VCap) associated with 
arterial blood gas analysis (ABGA), is an alternative to traditional examinations.
In this case report we present the results of clinical score (Wells), DD (Vidas®), 
and the VCap variables of a patient diagnosed with PE who was submitted for clinical 
treatment (dicoumarin). The DD, VCap, and image exams were conducted following 
admission to the hospital and again eight months after discharge (Table 1).Vascular Health and Risk Management 2010:6 318
Moreira et al Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
the patient had normal coronary arteries; ventriculography 
showed an ejection fraction of LV of 69%; important bulging 
in the abdominal region; amputation was present in peripheral 
branches, suggestive of multiple chronic emboli; and throm-
bus was located in the inferior lobe of the left lung, along with 
hypoperfusion of the middle segment in the lung right.
Eight months after the patient was discharged, a new lung 
scintigraphy (control), ELISA DD, and VCap were carried 
out. In comparison with the first round of tests, this scintigra-
phy revealed a discreet improvement in the perfusion pattern 
in the apical, anterior, posterior, and superior segments of 
the patient’s right lung. The DD result was 157.96 ng/mL. 
The ABGA in room air revealed PaO2 = 70.0 mmHg, 
PaCO2 = 30.0 mmHg, and SpO2 = 99%.
The association of VCap variables with ABGA allows for 
the calculation of several indices, the variations of which can 
infer the presence of occlusion or improve after treatment of 
pulmonary vessels.3–5
We determined the following parameters:
•	 AVDSf: PaCO2 − PetCO2/PaCO2;6
•	 fDlate = PaCO2 − Pet(15% CPT)CO2/PaCO2;7
•	 P(a-et)CO2: PaCO2
 – PetCO2.8
The calculation of fDlate attempts to avoid differences 
introduced in the functional dead space value by height, 
gender, and age. The use of an estimated tidal volume also 
eliminates the effect of the respiratory rate on tidal volume. 
In addition, the mathematical extrapolation of phase III 
of the CO2 expirogram at 15% of the total lung capacity 
(TLC) is aimed at bringing PetCO2 and PaCO2 into closer 
proximity. The TLC was obtained using the method devised 
by Grimby et al.9
Discussion
When an episode of PE occurs, the imbalance in the 
  ventilation/perfusion ratio is increased, and, consequently, the 
variables which form the functional dead space are altered. 
In the literature, we observe the following higher cut-off 
values for the studied variables: 0.15 for AVDSf,6 0.12 for 
fDlate,7 and 5 mmHg for P(a-et)CO2.8 Considering the fact 
that a higher calculated value indicates greater obstruction 
of the vascular system (and a larger alveolar dead space), we 
infer that there is a correlation between the extent of the area 
without perfusion and the value obtained.3–5 In this patient, the 
result of VCap variations were displayed in imaging results.
Breen et al10 in a similar case report, albeit without 
  follow-up and VCap, described a patient with acute PE 
with a similarly negative ELISA DD result (495.1 ng/mL). 
Case report
Our case study was a 25-year-old male smoker, who had 
symptoms of medium level dyspnea for one year. He was sent 
to a referral center for further investigation and underwent 
a transthoracic echocardiogram, which revealed “straddling 
thrombus”, or a moderate dilation of the chambers on the 
right side of the heart; additionally, his pulmonary artery 
systolic pressure was estimated at 78 mmHg and pulmo-
nary artery diastolic pressure was estimated at 22 mmHg. 
  Following the transthoracic echocardiogram, he was admit-
ted to hospital based on a preliminary diagnosis of PE and 
  treatment of anticoagulation with heparin was started.
In the physical examination the patients was found to 
be in generally good health. He was conscious, alert, dys-
pneic (22 bpm), had cyanosis of the extremities, a heart 
rate 88, arterial pressure of 150/110 mmHg, and did not have 
edema or tightening of the lower limbs. A pretest (Wells’ 
score) revealed there was a moderate probability that the 
patient had PE. ABGA in room air revealed PaO2 = 66.2; 
PaCO2 = 28.9 mmHg; and SpO2 = 98%.
Pulmonary scintigraphy showed heterogeneous distribu-
tion of perfusion in both lungs.
The ELISA DD levels were determined (VIDAS® D-dimer; 
bioMérieux, France); this test has a cutoff of 500 ng/mL. The 
sample taken on admission to the hospital was negative for PE 
(339.54 ng/mL; false-negative). The Doppler echocardiogram 
of the lower limbs showed no thrombi.
Respiratory dead space and functional space were 
determined through VCap (CO2SMO PLUS 8100®; Dixtal/
Novametrix, Brazil) associated with ABGA (Radiometer 
ABL® 700 Series; Radiometer Medical ApS, Denmark). The 
indices derived from these values were the end-tidal alveolar 
dead space fraction (AVDSf ), the late dead space fraction 
(f Dlate), and arterial-end-tidal CO2 gradient [P(a-et)CO2] 
(Table 1).
After a history of more than two weeks of development and 
maintaining clinical and hemodynamic stability, we suspected 
repeated and extensive PE, but chemical thrombolysis did 
not show improvement. A pulmonary arteriogram revealed 
Table 1 Vcap variables in admission and follow-up
  D-Dimer  AVDSf  fDLate  P(a-et)CO2 
(mmHg)
cut-off 500 ng/mL 0.15 0.12 5.0
Admission 339.54 ng/mL 0.42 0.38 12.0
Post-8 months 157.96 ng/mL 0.34 0.31 10.2
Abbreviations: *AVDsf, (end-tidal) alveolar dead space fraction; †Fdlate, late dead 
space fraction; ‡P(a-et)cO2, arterial-end-tidal gradient of cO2.Vascular Health and Risk Management 2010:6
Vascular Health and Risk Management
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/vascular-health-and-risk-management-journal
Vascular Health and Risk Management is an international, peer-
reviewed journal of therapeutics and risk management, focusing on 
concise rapid reporting of clinical studies on the processes involved 
in the maintenance of vascular health; the monitoring, prevention and 
treatment of vascular disease and its sequelae; and the involvement of 
metabolic disorders, particularly diabetes. This journal is indexed on 
PubMed Central and MedLine. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
319
capnography in patient with negative DD Dovepress
submit your manuscript | www.dovepress.com
Dovepress
Dovepress 
Ray et al11 using the same methodology ELISA (VIDAS®), 
obtained 12 false-negative results for patients with DVT or PE 
interned in emergency services. So, in rare cases where the 
symptoms are present over a long period of time, D-dimers 
might have become negative. However, results of our study 
show that there is an attenuate for this situation: the associa-
tion of a clinical pre-test + DD with VCap. Again, it should 
be emphasized that the association of noninvasive exams is 
essential (enhance sensibility).
It is known that when dealing with PE, anticoagulation is 
aimed at reducing the possibility of a new embolic phenom-
enon, as well as reducing the mortality risk. Therefore, imag-
ing tests are requested whenever there is clinical suspicion of 
PE. In spite of the fact that the diagnostic work-up for chronic 
PE is not the same as that for acute PE, noninvasive methods 
that rule out the possibility of PE would reduce the number 
of patients unnecessarily undergoing imaging tests.
Conclusions
In summary, we have presented the case of a patient with 
diagnosis of PE, which was confirmed through imaging tests 
and with altered pulmonary functional variables obtained 
through VCap tests. These variables followed the results of 
image exams throughout clinical intervention, highlight-
ing the importance of VCap as a potential noninvasive tool 
when used in association with measures of DD levels and 
clinical pretests. In rare situations, in patients with clinical 
pretest result suggesting moderate or high probability for 
PE, but with a negative DD result, an alternative test could 
be the VCap. Our results indicate it must be performed 
twice because in our case study the first time it paralleled 
the important vascular obstruction, and the second time it 
showed the absence of improvement. In this way we have 
demonstrated that VCap is a very interesting noninvasive 
tool to appreciate the vascular obstruction of a chronic 
thromboembolic disease.
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